Green Shield Canada

Medtronic has received a licence from Health Canada for its deep brain stimulation (DBS) therapy for refractory epilepsy patients. This delivers controlled electrical pulses to a location inside the brain involved in seizures.

Lot found to contain intact but empty capsules.

Safety and effectiveness may differ from brand-name products

New U.S. law will require pharmaceutical companies to declare payments to doctors

Health Canada has issued a medical device license for the Carestream DRX-Revolution mobile X-ray system.

New oral monotherapy for the treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma.

Approval means job of regulated pharmacy technicians will be harmonized across the country.

Drug is the first new oral anticoagulant that does not require routine laboratory monitoring.